Email Notification
Receive Daily Availability Emails
Sign Up| NDC# | Product | Strength | Supplied As | Shelf Pack | Inventory |
|---|---|---|---|---|---|
NDC#
0517-7604-25
|
Acetylcysteine Solution, USP |
20% |
4 mL vial |
25 | Limited Supply |
NDC#
0517-7504-25
|
Acetylcysteine Solution, USP |
10% |
4 mL vial |
25 | Limited Supply |
NDC#
0517-7630-03
|
Acetylcysteine Solution, USP |
20% |
30 mL vial |
3 | Out of Stock |
NDC#
0517-0401-25
|
Atropine Sulfate Injection, USP |
0.4 mg/mL |
1 mL Single Dose Vial |
25 | In Stock |
NDC#
0517-1010-25
|
Atropine Sulfate Injection, USP |
1 mg/mL |
1 mL Single Dose Vial |
25 | In Stock |
NDC#
0517-0720-01
|
Betamethasone Sodium Phosphate and Betamethasone Acetate Injectable Suspension, USP |
6 mg/mL |
5 mL |
1 | Limited Supply |
NDC#
0517-0920-01
|
Busulfan Injection |
60 mg/10 mL |
10 mL |
8 | In Stock |
NDC#
0517-2502-10
|
Caffeine and Sodium Benzoate Injection, USP |
250 mg/mL (125 mg/mL Caffeine) |
2 mL Single Dose Vial |
10 | In Stock |
NDC#
0517-0020-10
|
Caffeine Citrate Injection, USP |
20 mg/mL (10 mg/mL Caffeine Base) |
3 mL Single Dose Vial |
10 | In Stock |
NDC#
0517-6710-01
|
10% Calcium Chloride Injection, USP (FDA Approved) |
1 Gram (100 mg/mL) |
10 mL |
10 | Limited Supply |
NDC#
0517-2710-25
|
Calcium Chloride Injection, USP 10% (Marketed Unapproved) |
10% (100 mg/mL) |
10 mL |
25 | Out of Stock |
NDC#
0517-1820-01
|
Chlorothiazide Sodium For Injection, USP |
500 mg/ Lyophilized powder |
20 mL |
1 | In Stock |
NDC#
0517-0031-25
|
Cyanocobalamin (B12) Injection, USP |
1000 mcg/mL |
1 mL Vial |
25 | In Stock |
NDC#
0517-0130-05
|
Cyanocobalamin (B12) Injection, USP |
1000 mcg/mL |
30 mL Multiple Dose Vial |
5 | In Stock |
NDC#
0517-0032-25
|
Cyanocobalamin (B12) Injection, USP |
1000 mcg/mL |
10 mL Multiple Dose Vial |
25 | In Stock |
NDC#
0517-1980-01
|
Dicyclomine Hydrochloride Injection, USP |
20 mg/2 mL |
2 mL |
5 | Out of Stock |
NDC#
0517-9702-25
|
Droperidol Injection, USP |
5 mg/2 mL |
2 mL |
25 | Out of Stock |
NDC#
0517-1071-01
|
Epinephrine Injection, USP |
1 mg/mL |
1 mL ampule |
5 | Out of Stock |
NDC#
0517-0710-01
|
Fomepizole Injection |
1 g/mL |
1.5 mL |
1 | In Stock |
NDC#
0517-4605-25
|
Glycopyrrolate Injection, USP |
0.2 mg/mL |
5 mL Multiple Dose Vial |
25 | In Stock |
NDC#
0517-4620-25
|
Glycopyrrolate Injection, USP |
0.2 mg/mL |
20 mL Multiple Dose Vial |
25 | In Stock |
NDC#
0517-4601-25
|
Glycopyrrolate Injection, USP |
0.2 mg/mL |
1 mL Single Dose Vial |
25 | In Stock |
NDC#
0517-4602-25
|
Glycopyrrolate Injection, USP |
0.2 mg/mL |
2 mL Single Dose Vial |
25 | In Stock |
NDC#
0517-1767-01
|
Hydroxyprogesterone Caproate Injection, USP |
250 mg/mL |
1 mL |
1 | In Stock |
NDC#
0517-4201-25
|
Hydroxyzine HCl Injection, USP |
25 mg/mL |
1 mL |
25 | In Stock |
NDC#
0517-5602-25
|
Hydroxyzine HCl Injection, USP |
50 mg/mL |
2 mL |
25 | In Stock |
NDC#
0517-5601-25
|
Hydroxyzine HCl Injection, USP |
50 mg/mL |
1 mL |
25 | In Stock |
NDC#
0517-0375-05
|
Indigo Carmine Injection (Indigotindisulfonate Sodium Injection, USP) |
0.8% Solution | 5 mL Ampule | 5 | In Stock |
NDC#
0517-6410-25
|
Manganese Sulfate Injection, USP |
1 mg/10 mL (0.1 mg/mL) |
10 mL Single Dose Vial |
25 | In Stock |
NDC#
0517-1825-01
|
Methocarbamol Injection, USP |
100 mg/mL |
10 mL |
10 | Limited Supply |
NDC#
0517-0740-01
|
Methylergonovine Maleate Injection, USP |
0.2 mg/mL |
1 mL |
20 | In Stock |
NDC#
0517-7201-25
|
Multitrace®-4 |
Concentrate |
1 mL Single Dose Vial |
25 | In Stock |
NDC#
0517-7210-25
|
Multitrace®-4 |
Concentrate |
10 mL Multiple Dose Vial |
25 | Limited Supply |
NDC#
0517-7410-25
|
Multitrace®-4 |
— |
10 mL Multiple Dose Vial |
25 | In Stock |
NDC#
0517-9203-25
|
Multitrace®-4 |
Pediatric |
3 mL Single Dose Vial |
25 | Out of Stock |
NDC#
0517-9310-25
|
Multitrace®-4 |
Pediatric |
10 mL Multiple Dose Vial |
25 | Out of Stock |
NDC#
0517-6202-25
|
Multitrace®-4 |
Neonatal |
2 mL Single Dose Vial |
25 | In Stock |
NDC#
0517-8201-25
|
Multitrace®-5 |
Concentrate |
1 mL |
25 | In Stock |
NDC#
0517-8210-25
|
Multitrace®-5 |
Concentrate |
10 mL |
25 | In Stock |
NDC#
0517-8510-25
|
Multitrace®-5 |
— |
10 mL |
25 | In Stock |
NDC#
0517-1133-05
|
Neostigmine Methylsulfate Injection, USP |
5 mg/10 mL |
10 mL |
5 | In Stock |
NDC#
0517-1134-05
|
Neostigmine Methylsulfate Injection, USP |
10 mg/10 mL |
10 mL |
5 | In Stock |
NDC#
0517-4810-25
|
Nitroglycerin Injection, USP |
5 mg/mL |
10 mL Single Dose Vial |
25 | In Stock |
NDC#
0517-0955-01
|
Olanzapine For Injection, USP |
10 mg/Vial |
Single Use Vial |
1 | Out of Stock |
NDC#
0517-4002-25
|
Papaverine HCl Injection, USP |
30 mg/mL |
2 mL Single Dose Vial |
25 | In Stock |
NDC#
0517-0374-05
|
ProvayBlue® (methylene blue) Injection, 0.5%, USP |
5 mg/mL |
10 mL |
5 | In Stock |
NDC#
0517-6510-25
|
Selenium Injection (As Selenious Acid) |
40 mcg/mL |
10 mL |
25 | In Stock |
NDC#
0517-3005-25
|
Sterile Water For Injection, USP |
— |
5 mL Single Dose Vial |
25 | In Stock |
NDC#
0517-3010-25
|
Sterile Water For Injection, USP |
— |
10 mL |
25 | In Stock |
NDC#
0517-3020-25
|
Sterile Water For Injection, USP |
-- |
20 mL |
25 | In Stock |
NDC#
0517-0960-10
|
Tranexamic Acid Injection |
100 mg/mL |
10 mL Single Dose Vial |
10 | Out of Stock |
NDC#
0517-2310-05
|
Venofer® iron sucrose injection, USP |
200 mg/10 mL |
10 mL |
5 | In Stock |
NDC#
0517-2325-10
|
Venofer® iron sucrose injection, USP |
50 mg/2.5 mL |
2.5 mL |
10 | In Stock |
NDC#
0517-2340-10
|
Venofer® iron sucrose injection, USP |
100 mg/5 mL |
5 mL |
10 | In Stock |
NDC#
0517-2340-25
|
Venofer® iron sucrose injection, USP |
100 mg/5 mL |
5 mL |
25 | In Stock |
NDC#
0517-6110-25
|
Zinc Sulfate Injection, USP |
1 mg/mL |
10 mL |
25 | In Stock |
NDC#
0517-8105-25
|
Zinc Sulfate Injection, USP (Concentrated) |
5 mg/mL |
5 mL |
25 | In Stock |
FIND OUT FIRST
Receive daily availability emails
News Center
American Regent Announces the Launch and Availability of Fomepizole Injection, AP Rated and Therapeutically Equivalent to Antizol®
Shirley, NY — American Regent today announced the launch and availability of Fomepizole Injection, AP rated and therapeutically equivalent to Antizol®.
St. John’s University and American Regent Post-Doctoral Pharmaceutical Industry Fellowship
The program offers fellowships in both Medical Affairs & Pharmaceutical Marketing and in Clinical Research & Development.
American Regent Announces the FDA Approval of Hydroxyprogesterone Caproate Injection, USP; the First Preservative Free, AP Rated Generic to Makena®
Shirley, NY — American Regent today announced the launch of Hydroxyprogesterone Caproate Injection, USP, the only preservative free generic alternative to Makena®.